Literature DB >> 23740651

Supply-side response to declining heroin purity: fentanyl overdose episode in New Jersey.

Katherine Hempstead1, Emel O Yildirim.   

Abstract

The inelastic price demand observations characteristic of illegal drug markets have led to the conclusion that the burden of a negative supply shock would be completely reflected to consumers. This paper argues that the increasing availability of prescription opioids may threaten heroin sellers' profit margin and force them to find alternative methods to compensate buyers in the event of a supply shock. We investigate the 2006 fentanyl overdose episode in New Jersey and argue that the introduction of non-pharmaceutical fentanyl, its spatial distribution, and the timing of overdose deaths may have been related to trends in heroin purity. Using medical examiner data, as well as data from the Drug Enforcement Administration, Office of Diversion Control on retail sales of prescription opioids in a negative binomial specification, we show that month-to-month fluctuations in heroin purity have a significant effect on fentanyl-related overdoses, particularly in those areas where prescription opioids are highly available.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  illegal drugs; substance abuse; supply-side

Mesh:

Substances:

Year:  2013        PMID: 23740651     DOI: 10.1002/hec.2937

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  16 in total

1.  Illicit fentanyls in the opioid street market: desired or imposed?

Authors:  Sarah G Mars; Daniel Rosenblum; Daniel Ciccarone
Journal:  Addiction       Date:  2018-12-04       Impact factor: 6.526

2.  At-a-glance - Concurrent monitoring of opioid prescribing practices and opioid-related deaths: the context in Nova Scotia, Canada.

Authors:  Emily Schleihauf; Kirstin Crabtree; Carolyn Dohoo; Sarah Fleming; Heather McPeake; Matthew Bowes
Journal:  Health Promot Chronic Dis Prev Can       Date:  2018-09       Impact factor: 3.240

3.  Increase in Drug Overdose Deaths Involving Fentanyl-Rhode Island, January 2012-March 2014.

Authors:  Melissa C Mercado; Steven A Sumner; M Bridget Spelke; Michele K Bohm; David E Sugerman; Christina Stanley
Journal:  Pain Med       Date:  2018-03-01       Impact factor: 3.750

4.  The Rapidly Changing US Illicit Drug Market and the Potential for an Improved Early Warning System: Evidence from Ohio Drug Crime Labs.

Authors:  Daniel Rosenblum; Jay Unick; Daniel Ciccarone
Journal:  Drug Alcohol Depend       Date:  2020-01-07       Impact factor: 4.492

5.  Fentanyl and fentanyl-analog involvement in drug-related deaths.

Authors:  Zheng Dai; Marie A Abate; Gordon S Smith; James C Kraner; Allen R Mock
Journal:  Drug Alcohol Depend       Date:  2019-01-09       Impact factor: 4.492

6.  Sold as Heroin: Perceptions and Use of an Evolving Drug in Baltimore, MD.

Authors:  Sarah G Mars; Jeff Ondocsin; Daniel Ciccarone
Journal:  J Psychoactive Drugs       Date:  2017-12-06

7.  The Textures of Heroin: User Perspectives on "Black Tar" and Powder Heroin in Two U.S. Cities.

Authors:  Sarah G Mars; Philippe Bourgois; George Karandinos; Fernando Montero; Daniel Ciccarone
Journal:  J Psychoactive Drugs       Date:  2016-07-20

8.  The Rapid Escalation of Fentanyl in Illicit Drug Evidence in Allegheny County, Pennsylvania, 2010-2016.

Authors:  Kathleen E Creppage; Joshua Yohannan; Karl Williams; Jeanine M Buchanich; Thomas J Songer; Stephen R Wisniewski; Anthony Fabio
Journal:  Public Health Rep       Date:  2018-02-01       Impact factor: 2.792

Review 9.  Global Supply and Demand of Opioids for Pain Management.

Authors:  Sreekumar Kunnumpurath; Natasha Julien; Gopal Kodumudi; Anamika Kunnumpurath; Vijay Kodumudi; Nalini Vadivelu
Journal:  Curr Pain Headache Rep       Date:  2018-04-04

10.  Differences in time to injection onset by drug in California: Implications for the emerging heroin epidemic.

Authors:  Ricky N Bluthenthal; Daniel Chu; Lynn D Wenger; Philippe Bourgois; Thomas Valente; Alex H Kral
Journal:  Drug Alcohol Depend       Date:  2018-02-15       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.